Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The Scripps Research Institute
Biotech
Kojin bags $60M to exploit weakness of drug-resistant cancers
The series A positions the biotech to build on the work its scientific founders did at institutions including Harvard University and Dana-Farber.
Nick Paul Taylor
Jun 9, 2021 8:25am
Fused COVID 'nanobodies' from llamas and alpacas show promise
Jan 13, 2021 8:50am
Merck's oral cancer drug boosts PD-1 blockade in mice
Aug 20, 2020 2:00pm
Discoveries could inspire universal flu vaccine, new treatments
Oct 25, 2019 11:26am
Could a grape-based compound improve gene therapy efficiency?
Oct 20, 2019 10:25am
How nematode worms could inspire safer opioid use
Aug 15, 2019 2:00pm
